NBDF's Pathway to Cures Announces Spark Biomedical's LUNA Trial to Advance Non-Pharmaceutical Options for Heavy Menstrual Bleeding

For women and girls with bleeding disorders, heavy menstrual bleeding (HMB) is one of the most debilitating--and ignored--symptoms they endure. According to data from the National Bleeding Disorder's ...

Building Better Bleeding Disorders Therapies With NBDF Patient Panels

Pathway to Cures (P2C), the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), encourages biotech and pharmaceutical companies that are developing treatments and cures for ...
Morningstar

Hemab Therapeutics Presents Positive Clinical and Preclinical Data Across Bleeding Disorder Pipeline at ISTH 2025 Congress

COPENHAGEN, Denmark and CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved ...
Verywell Health on MSN

Types and causes of blood clotting disorders

Blood clotting disorders can be inherited or acquired and lead to either excessive bleeding or too much clotting.